CA Patent

CA2455167A1 — New pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2003-01-03 · 23y expired

What this patent protects

The invention relates to novel pharmaceutical compositions based on anitcholinergic agents, corticosteroids and betamimetic agents, to methods for the production thereof and to the use of the same for treating respiratory tract diseases.

USPTO Abstract

The invention relates to novel pharmaceutical compositions based on anitcholinergic agents, corticosteroids and betamimetic agents, to methods for the production thereof and to the use of the same for treating respiratory tract diseases.

Drugs covered by this patent

Patent Metadata

Patent number
CA2455167A1
Jurisdiction
CA
Classification
Expires
2003-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.